At the lowest threshold of 50 ng Hb/mL of buffer, and using only the first I-FOBT, sensitivity for CRC was 100% and 65% for all significant neoplasms (CRC or advanced adenomatous polyps). This evidence concerns the gene GSTM1 and colorectal carcinoma.